Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-β
about
Mechanisms of TGFβ-Induced Epithelial-Mesenchymal Transitionβ1 and β4 integrins: from breast development to clinical practiceExtracellular matrix as a contextual determinant of transforming growth factor-β signaling in epithelial-mesenchymal transition and in cancerThe TMEFF2 tumor suppressor modulates integrin expression, RhoA activation and migration of prostate cancer cellsN-ethylmaleimide-sensitive factor attachment protein α (αSNAP) regulates matrix adhesion and integrin processing in human epithelial cellsCombining antibody-directed presentation of IL-15 and 4-1BBL in a trifunctional fusion protein for cancer immunotherapy.Two faces of TGF-beta1 in breast cancer.Flipping the switch: integrin switching provides metastatic competenceIn PC3 prostate cancer cells ephrin receptors crosstalk to β1-integrins to strengthen adhesion to collagen type I.A cell-ECM screening method to predict breast cancer metastasis.Silencing β3 Integrin by Targeted ECO/siRNA Nanoparticles Inhibits EMT and Metastasis of Triple-Negative Breast Cancer.Tumor-induced remote ECM network orientation steers angiogenesis.NR4A1 Antagonists Inhibit β1-Integrin-Dependent Breast Cancer Cell Migration.MYC Is a Crucial Mediator of TGFβ-Induced Invasion in Basal Breast Cancer.Changing molecular profile of brain metastases compared with matched breast primary cancers and impact on clinical outcomesChamaejasmenin B, a novel candidate, inhibits breast tumor metastasis by rebalancing TGF-beta paradox.Cell adhesion molecules and their relation to (cancer) cell stemness.Integrin Ligands with α/β-Hybrid Peptide Structure: Design, Bioactivity, and Conformational Aspects.Penfluridol Represses Integrin Expression in Breast Cancer through Induction of Reactive Oxygen Species and Downregulation of Sp Transcription Factors.Covalent Targeting of Fibroblast Growth Factor Receptor Inhibits Metastatic Breast Cancer.MARVELD1 modulates cell surface morphology and suppresses epithelial-mesenchymal transition in non-small cell lung cancer.Inhibition of Transforming Growth Factor-β (TGF-β) Signaling by Scutellaria baicalensis and Fritillaria cirrhosa Extracts in Endometrial Cancer.β1 integrin inhibition elicits a prometastatic switch through the TGFβ-miR-200-ZEB network in E-cadherin-positive triple-negative breast cancer.Tuning Collective Cell Migration by Cell-Cell Junction Regulation.Silencing the roadblocks to effective triple-negative breast cancer treatments by siRNA nanoparticles.Mutant p53 dictates the oncogenic activity of c-Abl in triple-negative breast cancers.Electric field exposure promotes epithelial‑mesenchymal transition in human lens epithelial cells via integrin β1‑FAK signaling.Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses.Toxoplasma gondii induces FAK-Src-STAT3 signaling during infection of host cells that prevents parasite targeting by autophagy.Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases.β1 and β3 integrins in breast, prostate and pancreatic cancer: A novel implication.
P2860
Q26745545-49025A30-A5E2-4BA6-95F3-E6F463F991EFQ27000311-A65AE3E8-90AA-45F2-BE4D-77BC5410AE6BQ27005909-A2E3E06A-69CD-4C44-80B9-B528B043CD73Q28118861-FB0090AE-861B-48D8-83D9-38431361C28AQ30408477-24D066D6-30E3-4263-9404-D67ABEB57178Q30580198-F37E1358-2666-418B-B3EF-22E912701ED5Q33661529-214C060F-713D-4676-AFD0-CF98EF8A7FF3Q34402680-A5849832-C87D-40A0-98B6-ADF8F7869C15Q35040814-00F456A1-46FE-4A0A-825E-AA3AC8142979Q35070945-49DFBB0C-1CD4-44B2-87BC-94065D5B85ADQ35674830-E2D3B543-51CD-42F9-91C1-6728C4B273DDQ35941690-19CDD624-388C-4E5E-B547-BF8AC0C41C99Q36811554-9E857916-2574-4815-B86F-F0CE971E7EFDQ37014197-C5703FC3-882F-40C1-9186-8BDE10C02423Q37174919-A5F0E13F-88A6-460E-B526-E6FEF954D090Q37565425-60A17D4E-AE45-4C12-ACC7-9BDE4BFA5E3FQ38188463-B8E3D6D3-399F-4125-9055-56F39A698E75Q38700087-F7107EE6-DB9A-476E-9221-03BD58E13FCCQ38733122-7E60B98B-9639-41A3-900B-FAB9DFB8EFA1Q38760333-C99B96CE-9F98-481F-A5BC-A36E6954FB08Q38824234-8269EE28-A9AC-4913-B936-ED0B2BBFC9B3Q38909507-BC0D5BA2-6462-4AF3-A0B6-E1A9D18130EDQ39024860-C7D185C8-51D9-4581-B615-0D3F58E08EDFQ39092645-897EB66C-9ED6-4C4C-89A4-B1951F356F92Q39113994-812CDA5B-A008-4BED-8FA5-50DD4A11E43AQ41084432-987C08B3-4950-484D-9905-59A6D962A853Q42679461-737A69D8-4240-4E0C-BEFE-E64A537C8DB0Q44944214-552E2330-D62A-4691-9FA3-D54B8484CF52Q45070190-79DF2B47-6D04-414D-934E-80F9D5C753AAQ47881730-50E81735-A9CC-4865-AA89-D3EC5010B940Q52647715-450F76BE-8905-4267-95DB-32560F0DC85D
P2860
Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-β
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeted inactivation of β1 in ...... ast cancer metastasis by TGF-β
@en
Targeted inactivation of β1 in ...... st cancer metastasis by TGF-β.
@nl
type
label
Targeted inactivation of β1 in ...... ast cancer metastasis by TGF-β
@en
Targeted inactivation of β1 in ...... st cancer metastasis by TGF-β.
@nl
prefLabel
Targeted inactivation of β1 in ...... ast cancer metastasis by TGF-β
@en
Targeted inactivation of β1 in ...... st cancer metastasis by TGF-β.
@nl
P2093
P2860
P356
P1476
Targeted inactivation of β1 in ...... ast cancer metastasis by TGF-β
@en
P2093
Amy J Galliher-Beckley
Barbara J Schiemann
Jenny G Parvani
William P Schiemann
P2860
P304
P356
10.1091/MBC.E12-10-0776
P577
2013-09-04T00:00:00Z